Vaginal cancer risk factors: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 26: Line 26:
[[Category:Needs content]]
[[Category:Needs content]]
[[Category:Gynecology]]
[[Category:Gynecology]]
[[Category:Oncology]]

Revision as of 15:16, 30 August 2015

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Vaginal cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Vaginal cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Staging

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Vaginal cancer risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Vaginal cancer risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Vaginal cancer risk factors

CDC on Vaginal cancer risk factors

Vaginal cancer risk factors in the news

Blogs on Vaginal cancer risk factors

Directions to Hospitals Treating Vaginal cancer

Risk calculators and risk factors for Vaginal cancer risk factors

Overview

Who is at highest risk?

Clinical data has suggested that the development of vaginal cancer is related to several factors.

  • Vaginal adenosis: Clinical research suggest that having adenosis increases the risk of developing clear cell carcinoma. Although it is very small, many doctors feel that any woman with adenosis should have very careful screening and follow-up.
  • Cervical cancer: Surveies show having cervical cancer increases the risk of vaginal squamous cell cancer. This is most likely because cervical and vaginal cancers have similar risk factors.
  • Diethylstilbestrol (DES): Clinical data show women whose mothers took Diethylstilbestrol (DES) develop clear-cell adenocarcinoma of the vagina more often than would normally be expected. These women are called "DES daughters".
  • Human papillomavirus (HPV) infection: Certain types of HPV (type 16 and 18) have been strongly associated with vaginal cancers.
  • HIV infection: Clinical studies show human immunodeficiency virus (HIV) also increases the risk of vaginal cancer.
  • Unhealthy lifestyle: Epidemiological research demonstrates smoking and alcohol increase th erisk of vaginal cancer.
  • Age: Vaginal cancer is always found in women above 70 years old.

Risk Factors

Clear cell adenocarcinomas are rare and occur most often in patients less than 30 years of age who have a history of in utero exposure to diethylstilbestrol (DES). The incidence of this disease, which is highest for those exposed during the first trimester, peaked in the mid-1970s, reflecting the use of DES in the 1950s.[3] Young women with a history of in utero DES exposure should prospectively be followed carefully to diagnose this disease at an early stage. In women who have been carefully followed and well-managed, the disease is highly curable.

Vaginal adenosis is most commonly found in young women who had in utero exposure to DES and may coexist with a clear cell adenocarcinoma, though it rarely progresses to adenocarcinoma. Adenosis is replaced by squamous metaplasia, which occurs naturally, and requires follow-up but not removal. The natural history, prognosis, and treatment of other primary vaginal cancers (sarcoma, melanoma, lymphoma, and carcinoid tumors) may be different, and specific references should be sought.

References